200 related articles for article (PubMed ID: 29052817)
21. Attenuation of androgenic regulation by brefeldin A in androgen-responsive prostate cancer cells.
Alexander B; Fishman AI; Green D; Choudhury MS; Konno S
Urol Oncol; 2013 Jan; 31(1):104-9. PubMed ID: 21795077
[TBL] [Abstract][Full Text] [Related]
22. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
[TBL] [Abstract][Full Text] [Related]
23. Androgen metabolite-dependent growth of hormone receptor-positive breast cancer as a possible aromatase inhibitor-resistance mechanism.
Hanamura T; Niwa T; Nishikawa S; Konno H; Gohno T; Tazawa C; Kobayashi Y; Kurosumi M; Takei H; Yamaguchi Y; Ito K; Hayashi S
Breast Cancer Res Treat; 2013 Jun; 139(3):731-40. PubMed ID: 23780684
[TBL] [Abstract][Full Text] [Related]
24. Androgens induce sebaceous differentiation in sebocyte cells expressing a stable functional androgen receptor.
Barrault C; Garnier J; Pedretti N; Cordier-Dirikoc S; Ratineau E; Deguercy A; Bernard FX
J Steroid Biochem Mol Biol; 2015 Aug; 152():34-44. PubMed ID: 25864624
[TBL] [Abstract][Full Text] [Related]
25. An AKT activity threshold regulates androgen-dependent and androgen-independent PSA expression in prostate cancer cell lines.
Paliouras M; Diamandis EP
Biol Chem; 2008 Jun; 389(6):773-80. PubMed ID: 18627304
[TBL] [Abstract][Full Text] [Related]
26. Down-regulation of transforming growth factor beta receptors by androgen in ovarian cancer cells.
Evangelou A; Jindal SK; Brown TJ; Letarte M
Cancer Res; 2000 Feb; 60(4):929-35. PubMed ID: 10706107
[TBL] [Abstract][Full Text] [Related]
27. Nanog interaction with the androgen receptor signaling axis induce ovarian cancer stem cell regulation: studies based on the CRISPR/Cas9 system.
Ling K; Jiang L; Liang S; Kwong J; Yang L; Li Y; PingYin ; Deng Q; Liang Z
J Ovarian Res; 2018 May; 11(1):36. PubMed ID: 29716628
[TBL] [Abstract][Full Text] [Related]
28. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
29. Androgen receptor (AR) expression in AR-negative prostate cancer cells results in differential effects of DHT and IGF-I on proliferation and AR activity between localized and metastatic tumors.
Plymate SR; Tennant MK; Culp SH; Woodke L; Marcelli M; Colman I; Nelson PS; Carroll JM; Roberts CT; Ware JL
Prostate; 2004 Nov; 61(3):276-90. PubMed ID: 15368471
[TBL] [Abstract][Full Text] [Related]
30. Aging up-regulates ARA55 in stromal cells, inducing androgen-mediated prostate cancer cell proliferation and migration.
Zou Q; Cui D; Liang S; Xia S; Jing Y; Han B
J Mol Histol; 2016 Jun; 47(3):305-15. PubMed ID: 27178620
[TBL] [Abstract][Full Text] [Related]
31. Homologous androgen receptor up-regulation in osteoblastic cells may be associated with enhanced functional androgen responsiveness.
Wiren K; Keenan E; Zhang X; Ramsey B; Orwoll E
Endocrinology; 1999 Jul; 140(7):3114-24. PubMed ID: 10385404
[TBL] [Abstract][Full Text] [Related]
32. Androgen Receptor-Mediated Genomic Androgen Action Augments Ischemia-Induced Neovascularization.
Lam YT; Lecce L; Tan JT; Bursill CA; Handelsman DJ; Ng MK
Endocrinology; 2016 Dec; 157(12):4853-4864. PubMed ID: 27754785
[TBL] [Abstract][Full Text] [Related]
33. Dihydrotestosterone interacts with EGFR/MAPK signalling and modulates EGFR levels in androgen receptor-positive LNCaP prostate cancer cells.
Mukherjee B; Mayer D
Int J Oncol; 2008 Sep; 33(3):623-9. PubMed ID: 18695894
[TBL] [Abstract][Full Text] [Related]
34. Androgen receptor expression in primary prostate cancers of Lobund-Wistar rats and in tumor-derived cell lines.
Bentel JM; Pickering MA; Pollard M; Clements JA; Tilley WD
In Vitro Cell Dev Biol Anim; 1999; 35(10):655-62. PubMed ID: 10614877
[TBL] [Abstract][Full Text] [Related]
35. Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus.
Tihan T; Harmon JW; Wan X; Younes Z; Nass P; Duncan KL; Duncan MD
Anticancer Res; 2001; 21(4B):3107-14. PubMed ID: 11712819
[TBL] [Abstract][Full Text] [Related]
36. Effects of 2,4-D and DCP on the DHT-induced androgenic action in human prostate cancer cells.
Kim HJ; Park YI; Dong MS
Toxicol Sci; 2005 Nov; 88(1):52-9. PubMed ID: 16107550
[TBL] [Abstract][Full Text] [Related]
37. Comparison of prostate cancer cell lines for androgen receptor-mediated reporter gene assays.
Kim HJ; Park YI; Dong MS
Toxicol In Vitro; 2006 Oct; 20(7):1159-67. PubMed ID: 16621434
[TBL] [Abstract][Full Text] [Related]
38. Synergistic activation of the androgen receptor by bombesin and low-dose androgen.
Dai J; Shen R; Sumitomo M; Stahl R; Navarro D; Gershengorn MC; Nanus DM
Clin Cancer Res; 2002 Jul; 8(7):2399-405. PubMed ID: 12114445
[TBL] [Abstract][Full Text] [Related]
39. 11-Ketotestosterone and 11-Ketodihydrotestosterone in Castration Resistant Prostate Cancer: Potent Androgens Which Can No Longer Be Ignored.
Pretorius E; Africander DJ; Vlok M; Perkins MS; Quanson J; Storbeck KH
PLoS One; 2016; 11(7):e0159867. PubMed ID: 27442248
[TBL] [Abstract][Full Text] [Related]
40. Hypoxia enhances transcriptional activity of androgen receptor through hypoxia-inducible factor-1α in a low androgen environment.
Mitani T; Yamaji R; Higashimura Y; Harada N; Nakano Y; Inui H
J Steroid Biochem Mol Biol; 2011 Jan; 123(1-2):58-64. PubMed ID: 21056661
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
